PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026BMJ Case Reports0 citations

Multiple opportunistic infections revealing Erdheim–Chester disease: an atypical presentation

View Full Paper
BGBrenda González-BedollaTecnológico de MonterreyFLFrancisco A. Luna-RangelHospital Zambrano HellionXGXitlaly J Gonzalez-LealTecnológico de Monterrey

Key Points

  • This case aims to highlight Erdheim–Chester disease as a rare cause of multisystem disease, particularly when opportunistic infections are present.
  • Reported clinical presentation with respiratory failure and elevated inflammatory biomarkers.
  • Conducted a PET-CT scan to identify variable uptake in multiple body locations.
  • Performed a bone biopsy to confirm diagnosis of histiocytosis through specific biomarkers.
  • Diagnosed Erdheim–Chester disease via confirmed clonal histiocytosis biomarkers.
  • Initiated treatment with pegylated interferon alpha due to unavailability of vemurafenib.
  • Significant clinical and biomarker improvements were observed, leading to patient discharge in stable condition.

Abstract

This case describes a man in his mid 60s from Mexico who presented with respiratory failure and elevated inflammatory biomarkers. Initial investigations revealed multiple opportunistic infections. A PET-CT scan showed variable uptake in bilateral intraconal masses, dural venous sinuses, paranasal sinuses, lungs, pericardium and both distal femurs. Bone biopsy confirmed clonal histiocytosis (CD68+, CD163+, Fascin+, BRAF-V600E+), leading to a diagnosis of Erdheim–Chester disease (ECD), a rare non-Langerhans histiocytosis affecting multiple systems. As vemurafenib was unavailable in Mexico, pegylated interferon alpha (PEG-IFN-α) was initiated, producing significant clinical and biomarker improvement. The patient was discharged in stable condition and continues close multidisciplinary follow-up with infectious disease, cardiology, nephrology, pulmonology and haematology teams. This case highlights the importance of considering ECD in the differential diagnosis of multisystem diseases of unknown origin, especially with unusual manifestations such as multiple opportunistic infections, and reinforces the value of a coordinated, multidisciplinary approach in managing complex presentations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

González-Bedolla et al. (2026) studied this question.

synapsesocial.com/papers/69994c80873532290d021129https://doi.org/10.1136/bcr-2025-269136
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in Understanding and Management of Erdheim-Chester Disease2024 · 18 citations
  2. 2The clinical spectrum of Erdheim-Chester disease: an observational cohort study2017 · 250 citations
  3. 3Erdheim-Chester Disease With Extensive Pericardial Involvement: A Case Report and Systematic Review2020 · 10 citations
  4. 4“Hairy Kidney” in Erdheim–Chester Disease2023 · 3 citations
  5. 5Tc-99m MDP Bone Scintigraphy and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Erdheim-Chester Disease2006 · 24 citations